Shifting Paradigm: A New Era in Treating Spinal Muscular Atrophy

Watch these dynamic presentations and roundtables from multidisciplinary experts to learn how you can improve screening, diagnosis, and management of spinal muscular atrophy in pediatric patients.

Samiah Al-Zaidy, MD Vanessa Battista, MS, RN, CPNP Nancy L. Kuntz, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Nurse Practitioners: 1.25 NAPNAP CE contact hours Released: September 3, 2020 Expired: September 2, 2021

Introduction (1 min)

Understanding the Genetic Basis of SMA (15 mins)

Diagnosis and Considerations After Treatment (22 mins)

Early Action With Treatment (28 mins)

Considerations After Treatment (12 mins)

How can you improve the screening and diagnosis of spinal muscular atrophy (SMA) and what treatments options are available to discuss with families? View, download, and share these expert slides on SMA.

Samiah Al-Zaidy, MD Vanessa Battista, MS, RN, CPNP Nancy L. Kuntz, MD Released: September 3, 2020

Even with treatments now available for SMA, clinicians must be mindful that we are still giving the diagnosis of a lifelong chronic illness requiring support for both child and family. Here, I share my perspective on how best to support, counsel, and educate families during this challenging period.

Vanessa Battista, MS, RN, CPNP Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Nurse Practitioners: 0.25 NAPNAP CE contact hours Released: October 5, 2020 Expired: October 4, 2021

With 3 FDA-approved agents now available for SMA, here’s my summary of the most clinically important information to help you educate families and assist them in making decisions about treatment.

Nancy L. Kuntz, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Nurse Practitioners: 0.25 NAPNAP CE contact hours Released: October 23, 2020 Expired: October 22, 2021